Park Young Min, Yoon Sun Och, Kim Joo Hyun, Kang Min Seok, Kim Da Hee, Koh Yoon Woo, Kim Se-Heon, Lim Jae-Yol, Choi Eun Chang
Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea.
Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Clin Exp Otorhinolaryngol. 2021 Feb;14(1):108-115. doi: 10.21053/ceo.2019.01550. Epub 2020 May 13.
In subset of patients, acinic cell carcinoma (AcCC) exhibits aggressive features such as recurrence, distant metastasis, and mortality. This study aimed to investigate clinicopathologic factors influencing patients' prognosis and to identify adverse features predictive of an unfavorable prognosis.
Between January 2000 and December 2016, 59 patients with AcCC were enrolled in this study.
The patients' 5-year overall survival rate was 93.3%, and their 5-year recurrence-free survival rate was 80.5%. During the study period, recurrence occurred in 10 patients. The mean time to recurrence after surgery was 26 months (range, 5-60 months). During the study period, three patients died from the disease. Univariate analysis showed that sex, surgical extent, extranodal extension, T classification, and TNM stage were significantly associated with disease recurrence. Multivariate analysis showed that, among the clinicopathologic factors included in the analysis, only TNM stage displayed a statistically significant correlation with disease recurrence.
Surgical treatment alone yielded good results for AcCC, and additional treatment did not affect the recurrence-free survival rate or the overall survival rate, even when the resection margin was less than 1 mm. Other pathologic factors did not show prognostic significance for disease recurrence or death.
在部分患者中,腺泡细胞癌(AcCC)表现出侵袭性特征,如复发、远处转移和死亡。本研究旨在调查影响患者预后的临床病理因素,并确定预测不良预后的不良特征。
2000年1月至2016年12月期间,本研究纳入了59例腺泡细胞癌患者。
患者的5年总生存率为93.3%,5年无复发生存率为80.5%。在研究期间,10例患者出现复发。术后复发的平均时间为26个月(范围为5 - 60个月)。在研究期间,3例患者死于该疾病。单因素分析显示,性别、手术范围、结外扩展、T分类和TNM分期与疾病复发显著相关。多因素分析显示,在分析纳入的临床病理因素中,只有TNM分期与疾病复发存在统计学显著相关性。
单纯手术治疗对腺泡细胞癌产生了良好的效果,即使切缘小于1毫米,额外治疗也不影响无复发生存率或总生存率。其他病理因素对疾病复发或死亡未显示出预后意义。